NYSE: NMRNomura Holdings Inc Stock
$5.81-0.10 (-1.69%)
Updated Apr 25, 2024
NMR Price
$5.81
Fair Value Price
N/A
Market Cap
$17.45B
52 Week Low
$3.38
52 Week High
$6.62
P/E
28.48x
P/B
0.84x
P/S
1.14x
PEG
0.19x
Dividend Yield
N/A
Revenue
$8.81B
Earnings
$700.80M
Gross Margin
91.1%
Operating Margin
11.27%
Profit Margin
6.9%
Debt to Equity
14.15
Operating Cash Flow
-$5B
Beta
0.77
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NMR Overview
Nomura Holdings, Inc. offers securities, investment and other financial sevices to individuals, corporations, financial institutions, and governments. Its Sales segment provides investment consultation services to individual clients in Japan. The Asset Management segment offers development and management of investment trusts and investment advisory services. The Wholesale segment sells and trade bonds, equity securities, derivatives and foreign exchange. Nomura Holdings was incorporated in 1925 and is headquartered in Tokyo, Japan.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NMR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NMR ($5.81) is trading below its intrinsic value of $11.78, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NMR is good value based on its earnings relative to its share price (28.48x), compared to the US market average (40.97x)
P/E vs Market Valuation
NMR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NMR due diligence checks available for Premium users.
Be the first to know about important NMR news, forecast changes, insider trades & much more!
NMR News
Valuation
NMR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.48x
Industry
19.26x
Market
40.97x
NMR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NMR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NMR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.84x
Industry
1.86x
NMR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NMR price to earnings growth (PEG)
For valuing profitable companies with growth potential
NMR is good value based... subscribe to Premium to read more.
PEG Value Valuation
NMR's financial health
Profit margin
Revenue
$10.1B
Net Income
$700.8M
Profit Margin
6.9%
NMR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$360.8B
Liabilities
$336.5B
Debt to equity
14.15
NMR's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NMR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.2B
Investing
-$1.8B
Financing
$9.7B
NMR vs Capital Market Stocks
Nomura Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.